BioRem Inc.
3.67CAD
-0.0400 (-1.08%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BRM.V.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current year | CA$0.34▲ | CA$0.3 | 1 | 0 |
| Next year | CA$0.43▲ | CA$0 | 0 | 0 |
19 filings from 3 insiders · 0 buy / 0 sell over 6m
Officers and directors of BRM.V, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Webb (Derek)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | Exercise | 1.16M | $0.24 | $281k | Sep 29, 2026 |
| Newman (Douglas)Senior Officer of Issuer | Exercise | 300.0k | $0.24 | $73k | Sep 28, 2026 |
| Newman (Douglas)Senior Officer of Issuer | Sell | 10.8k | $2.42 | $26k | Sep 22, 2026 |
| Newman (Douglas)Senior Officer of Issuer | Sell | 4.2k | $2.42 | $10k | Sep 22, 2026 |
| Newman (Douglas)Senior Officer of Issuer | Sell | 10.7k | $2.44 | $26k | Sep 22, 2026 |
| Newman (Douglas)Senior Officer of Issuer | Sell | 3.8k | $2.46 | $9k | Sep 22, 2026 |
| Newman (Douglas)Senior Officer of Issuer | Sell | 500 | $2.47 | $1k | Sep 22, 2026 |
| Webb (Derek)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | Sell | 28.7k | $2.76 | $79k | Aug 24, 2026 |
| Webb (Derek)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | Sell | 6.3k | $2.78 | $17k | Aug 21, 2026 |
| Webb (Derek)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | Sell | 15.0k | $2.71 | $41k | Aug 20, 2026 |
| Webb (Derek)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | Exercise | 90.0k | $0.24 | $22k | Jun 29, 2026 |
| Biorem IncIssuer | Other | 10.7k | — | — | Jun 26, 2026 |
| Biorem IncIssuer | Other | 10.7k | $2.14 | $23k | Jun 26, 2026 |
| Biorem IncIssuer | Other | 300 | — | — | Jun 10, 2026 |
| Biorem IncIssuer | Other | 300 | $2.18 | $654 | Jun 10, 2026 |
| Biorem IncIssuer | Other | 900 | — | — | Jun 8, 2026 |
| Biorem IncIssuer | Other | 900 | $2.18 | $2k | Jun 8, 2026 |
| Biorem IncIssuer | Other | 1.0k | — | — | Jun 5, 2026 |
| Biorem IncIssuer | Other | 1.0k | $2.18 | $2k | Jun 5, 2026 |
Analyst Ratings
1 analyst covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 0 | 0 | 0 | 0 | Strong Buy1.00 |
Members whose judged calls on BRM.V have played out most reliably.
No settled calls on BRM.V yet. 1 call is open, the first due Oct 23, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice